Check the time stamp on this data. Updated AI-Generated Signals for Hims & Hers Health Inc. Class A (HIMS) available here: ...

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors.

Hims & Hers' robust Q3 2024 performance, driven by a 44% increase in subscribers and 77% y/y revenue growth, underscores its ...

Haveri: Haveri Institute of Medical Sciences (HIMS) introduced a groundbreaking mobile application, ‘HIMS Haveri', establishing itself as the pioneer .

Hims & Hers is transforming telehealth with personalized medications, rapid subscription growth, and strong financials, ...

Americans largely believe that losing weight can make a big difference both in daily life and in the country as a whole. In ...

Haveri: A total of 178 medical personnel at Haveri District Hospital and Haveri Institute of Medical Sciences (HIMS) have not received their wages for.

Three unlikely winners of 2024 can lead the way in the year ahead. Some of the hottest stocks of 2024 may surprise you. A few ...

2025年1月2日，保健护理服务公司Hims & Hers Health（HIMS）成交额为2.40亿美元，在当日美股中排第290名，成交额较昨日增加10.15%，当日成交量为956.05万。 Hims & Hers Health（HIMS）于2025年1月2日涨4.22%，报25.2美元，该股过去5个交易日跌11.55%，整个1月涨4.22%，年初至今涨4.22%，过去52周涨178.45%。

Hot telehealth stock Hims & Hers Health (NYSE: HIMS) has been a roller coaster in 2024. After a recent decline, the stock is down more than 25% from its high. Yet Hims & Hers is still up nearly ...

Hims & Hers sells compounded GLP-1 agonists, which have become its identity in the eyes of the market. The company is poised to grow, even if it must shut down its compounded GLP-1 agonist business.